Piramal Alternatives India Credit Opportunities Fund II
Piramal Alternatives India Credit Opportunities Fund II is a dedicated performing-credit vehicle providing growth and refinancing capital to mid-market Indian businesses. Public fund-attributed announcements identify Saimirra Innopharm, JRG Automotive Industries and Kolors Healthcare; Piramal’s materials describe a sector-agnostic three-to-four-year strategy and a ₹2,000 crore target domestic fund-raise including green-shoe capacity.
At a glance
- Founded
- 2023
- Footprint
- Mumbai
- Stage
- Performing private credit; growth and refinancing capital
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Piramal Alternatives India Credit Opportunities Fund II uses a performing private credit; growth and refinancing capital approach across Healthcare, pharmaceuticals, industrials, consumer and automotive.
Current evidence
Piramal Alternatives announced a ₹215 crore PCF II investment in Kolors Healthcare on 2026-08-26, following a ₹125 crore PCF II investment in JRG Automotive Industries announced in July 2026. The manager’s current public materials identify PCF II as a dedicated performing-credit fund.
Strategy
Performing private credit; growth and refinancing capital
Sector focus
Healthcare, pharmaceuticals, industrials, consumer and automotive
Current signal
Piramal Alternatives announced a ₹215 crore PCF II investment in Kolors Healthcare on 2026-08-26, following a ₹125 crore PCF II investment in JRG Automotive Industries announced in July 2026. The manager’s current public materials identify PCF II as a dedicated performing-credit fund.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.